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Abstract.  Torpedo electroplaque and vertebrate neu- 
romuscular junctions contain high levels of a  nonactin, 
43,000-Mr peripheral  membrane protein referred to as 
the 43K protein. 43K protein is associated with the 
cytoplasmic face of postsynaptic membranes at areas 
of high acetylcholine receptor density and has been 
implicated in the establishment and/or maintenance of 
these receptor clusters. Cloning of cDNAs encoding 
Torpedo 43K protein revealed that its amino terminus 
contains a  consensus sequence sufficient for the cova- 
lent attachment of the rare fatty acid myristate. To ex- 
amine whether 43K protein is,  in fact, myristoylated, 
mouse muscle BC3H1  cells were metabolically labeled 
with either [35S]cysteine or [3H]myristate and immuno- 
precipitated with a  monospecific antiserum raised 
against isolated Torpedo 43K protein. In cells in- 
cubated with either precursor,  a  single labeled species 
was specifically recovered that comigrated on SDS- 
PAGE with 43K protein purified from Torpedo electric 
organ. Approximately 95%  of the 3H labeled material 
released from [3H]myristate-43K protein by acid 
methanolysis was extractable in organic solvents and 
eluted from a  C~8 reverse-phase HPLC column exclu- 
sively at the position of the methyl myristate internal 
standard.  Thus, 43K protein contains authentic myris- 
tic acid rather than an amino or fatty acid metabolite 
of [3H]myristate. Myristate appears to be added to 43K 
protein cotranslationally and cannot be released from 
it by prolonged incubation in SDS,  2-mercaptoethanol, 
or hydroxylamine (pH 7.0 or  10.0),  characteristics con- 
sistent with amino terminal myristoylation. Covalently 
linked myristate may be responsible for the high 
affinity of purified 43K protein for lipid bilayers de- 
spite the absence of a  notably hydrophobic amino acid 
sequence. 
T 
HE nicotinic acetylcholine receptor (nAchR) ~ is im- 
mobilized in stable, high density arrays on the post- 
synaptic  membrane  of Torpedo  electric  organ  and 
vertebrate  neuromuscular synapses (2). The molecular mech- 
anisms that are responsible for this distribution are largely 
unknown but appear to involve both extracellular matrix (2, 
34, 36) and intracellular components (21). A distinctive fea- 
ture of neuromuscular nicotinic cholinergic synapses thought 
to play a key role in the maintenance of nAchR clusters is 
a specialized network of structural proteins localized to the 
cytoplasmic membrane face of the clusters (25, 52). Among 
proteins that have been identifed in this meshwork in muscle 
are ~t-actinin (4), filamin (4), vinculin (4), talin (54), and a 
nonsarcomeric form of actin (24), all known elements of the 
cytoskeleton of many cell types. In addition, a  peripheral 
membrane protein of 43,000 Mr that appears to be unique to 
skeletal muscle and electroplaque cells (30) is a prominent 
component of the synaptic apparatus (39, 45, 59). This latter 
polypeptide is clearly distinct from actin (45, 60) and is re- 
ferred to simply as the 43K protein. 
1. Abbreviation used in this paper: nAchR, nicotinic acetylcholine receptor. 
The 43K protein was first described as a major protein of 
nAchR-rich postsynaptic membranes isolated from Torpedo 
electric organ (56, 57) where it is found in quantities roughly 
equal to that of receptor (30).  A close association between 
43K protein and the nAchR was suggested by the remarkably 
exact colocalization of these proteins in the electrocyte post- 
synaptic membrane (53) and the ability of 43K protein to be 
chemically cross-linked to the 13 subunit of the nAchR in iso- 
lated membrane fragments (9).  More recently, evidence for 
a direct association between 43K protein and the nAchR has 
been obtained using freeze-fracture immunoelectron micros- 
copy (7). The 43K protein is very tightly bound to the elec- 
troc3~te membrane, requiring alkaline solutions (pH >111) or 
the chaotropic agent lithium diiodosalicylate to dissociate it 
from  isolated  nAchR-rich  membrane  fragments  (19, 38). 
Removal of 43K protein by these means does not affect the 
Ach-activated permeability characteristics of the nAchR (38) 
but markedly increases the lateral (1, 17) and rotational (49) 
mobility of the receptor in the plane of the plasma mem- 
brane. The skeletal muscle counterpart of Torpedo 43K pro- 
tein has been localized by immunofluorescence microscopy 
to the cytoplasmic face of the postsynaptic membrane of ver- 
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innervated and aneural nAchR clusters on cultured muscle 
cells (8, 44). As in Torpedo postsynaptic membranes, there 
is a precise correspondence in the distribution of immuno- 
logically detected 43K protein and nAchR in these cells (44), 
with both proteins accumulating at newly forming nerve- 
muscle synapses at the same rate (8).  Skeletal  muscle 43K 
protein also resembles the Torpedo protein in being associ- 
ated with nAchR clusters on receptor-rich membrane frag- 
ments and because redistribution of these nAchRs occurs 
upon its removal with either high pH or lithium diiodosalicy- 
late (5).  Thus, the 43K proteins from skeletal muscle and 
from electrocytes most likely share  functional as  well as 
structural similarities. 
The amino acid sequence of Torpedo 43K protein was de- 
termined by cDNA cloning (20) and direct protein sequenc- 
ing of purified 43K protein (16). Consistent with the known 
physical properties of Torpedo 43K protein,  the sequence 
was found to be very rich in cysteine and lacking in classic 
hydrophobic membrane spanning regions. Interestingly, the 
amino terminus of Torpedo 43K protein is blocked to Edman 
degradation (16) and was deduced from the cDNA sequence 
to be Met-Gly-Gln-Asp-Gln-Thr (20). Recent studies by Frail 
et al. (19a) demonstrate that the cDNA-derived sequence of 
mouse muscle 43K protein begins with an identical hexapep- 
tide. Assuming cotranslational removal of  the initiator methi- 
onine,  this  sequence  contains  a  combination of features 
(NH2-terminal  glycine; small, uncharged residues in posi- 
tions 2 and 5) demonstrated by Towler et al. (63-65) to con- 
stitute a consensus sequence for amino terminal addition of 
the saturated  14-carbon  fatty acid,  myristate.  Myristoyla- 
tion, unlike palmitylation, is a relatively rare modification 
that has been described for only a handful of cellularly en- 
coded proteins (65).  To examine whether 43K protein con- 
tains covalently bound myristate, we have developed a pro- 
tocol for the metabolic labeling and immunoprecipitation of 
this protein from the murine muscle cell line BC3H1. BC3H1 
cells have been well-characterized in terms of their fatty acy- 
lation of proteins  (40,  42,  62)  and have  been  shown by 
LaRochelle and Froehner to  contain a  43,000-Mr  protein 
that  is  specifically recognized  by  monoclonal  antibodies 
raised against Torpedo 43K protein (31). We report here that 
43K protein can be metabolically labeled with [3H]myris- 
tate in BC3H1 cells. Chemical characterization of the 3H-la- 
beled moiety of immunoprecipitated 43K protein demon- 
strated that [3H]myristate is covalently incorporated into the 
43K  protein  as  authentic myristate via a  hydroxylamine- 
resistant (presumably amide) bond, as expected for a protein 
containing NH2-terminal  myristoylglycine. In analogy to its 
proposed function in certain other proteins, myristate may be 
involved in the association of 43K protein with the inner sur- 
face of the plasma membrane. 
Materials and Methods 
Anti-43K Serum and Monoclonal Antibodies 
Electrophoretically pure 43K protein was isolated from Torpedo  californica 
electric organ postsynaptic membranes by preparative SDS-PAGE (16) and 
used as the immunogen for production of polyclonal anti-43K serum. A 
New Zealand white rabbit was immunized with complete Freund's adjuvant 
containing 50 I.tg purified 43K protein by subcutaneous injection and was 
boosted at 5-wk intervals, each time with 50 p.g 43K protein in incomplete 
Freund's adjuvant.  Characterization of this antiserum is provided in the 
Results section. 
The  mouse monoclonal antibody,  mAb  19F4a,  was generated as de- 
scribed by Bridgman et al. (7) except that partially purified preparations of 
43K protein (pH 11 extracts of Torpedo postsynaptic membranes) were used 
as immunogen. This antibody reacts uniquely with the 43K protein on one- 
and two-dimensional immunoblots of Torpedo electric organ proteins. Total 
nAchR ¢t subunit was detected with the rat monoclonal antibody mAb 61 
which is specific for the et subunit and has been characterized by Tzartos 
et al.  (66) and Merlie and Lindstrom (37). 
Cell Culture and Labeling Conditions 
The BC3H1 mouse muscle cell line (50) was grown as described by Merlie 
and Lindstrom (37). 7-d-old confluent 60-mm cultures of BC3HI cells were 
used for all experiments. 
BC3H1  cultures were labeled with [35S]cysteine  by removing one-half 
(2.5 ml) of the growth medium and adding 0.25 mCi [3SSlcysteine (>600 
Ci/mmol; Amersham Corp., Arlington Heights, IL) directly to the remain- 
ing medium. Labeling time was 4  h.  For labeling with 3H fatty acids, a 
modification of the procedure of Olson et al. (40) was used. Cultures were 
rinsed 3 times in DME (high glucose/high bicarbonate formulation) and in- 
cubated for 4 h in the same medium supplemented with 5% delipidated and 
dialyzed FCS, L-glutamine (0.1 mg/ml), 6 mM pyruvate, and either [9,  10- 
3H(N)]  myristate (20-40 Ci/mmol; New  England Nuclear, Boston, MA) 
or [9,  i0-3H(N)I palmitate (20-40 Ci/mmol; New England Nuclear).  1/2 
mCi of tritiated fatty acid was used per plate. 
Preparation of  Cell Lysates 
At the end of labeling, medium was removed and cultures were rinsed three 
times with PBS followed by a single wash with "extraction buffer" (0.05 M 
NaCl, 0.01 M  Hepes, 2.5 mM MgCl2, 0.3 M  sucrose, 2 mM phenylmeth- 
ylsulfonyl fluoride [PMSF], pH 7.4) (3). Cultures werre placed on ice and 
incubated for 2 rain at 4°C with 1 ml of extraction buffer with 0.5% Triton 
X-100  and protease  inhibitors (200  p.M  leupeptin, 0.2  mg/ml ct2-macro- 
globulin. 50 I.tg/ml aprotinin, and 500 I.tM benzamidine). Cells were then 
scraped from the plate with a rubber policeman and incubated at 4°C for 
15  min to solubilize membranes. Preliminary experiments demonstrated 
that reactivity of the anti-43K serum with 43K protein was markedly en- 
hanced if the Triton-solubilized cell lysates were denatured and alkylated 
before immunoprecipitation. The lysates were therefore incubated with 0.2 % 
SDS and 10 mM N-ethylmaleimide at 4°C for 10 min, after which they were 
passed three times through a 27-gauge needle to shear DNA released from 
lysed nuclei. Samples were then diluted with an equal volume of extraction 
buffer supplemented with 0.5% Triton X-100 and t0 mM N-etbylmaleimide 
before immunoprecipitation. 
lmmunoprecipitations 
For immunoprecipitation with anti-43K serum, samples of cell lysates pre- 
pared as described above were first precleared with  100 mg of Immuno- 
Precipitin  (Bethesda Research Laboratories,  Gaithersburg,  MD;  61) and 
were then incubated overnight at 4°C  in the presence of 0.5%  BSA and 
saturating amounts of antiserum. In general, 5 gl of antiserum (bleed 5) was 
used to immunoprecipitate 43K protein from one-fifth of the total cell lysate 
prepared from a confluent 60-ram plate of BC3H1 cells. The resulting im- 
mune complexes were precipitated by addition of excess Immuno-Precipitin 
and after a 20-rain incubation at 4°C with mixing, collected by centrifuga- 
tion.  Supernatants were  discarded,  and the pelleted  immunoprecipitates 
were washed five times by suspension in 1 ml of buffer followed by centrifu- 
gation for 5 min in a centrifuge (Eppendorf 5413). The buffer for the first 
four washes was 0.1  M  NaCI, 0.02 M  Na borate,  15 mM EGTA,  15 mM 
EDTA, 0.02% Na azide,  10 mM N-ethylmaleimide, pH 8.5,  ("immunopre- 
cipitation buffer") supplemented with 0.5% Triton X-100, 0.1%  SDS, 0.5% 
BSA, and 0.5 M  sucrose. After the fourth wash pellets were resuspended 
in immunoprecipitation buffer supplemented with 0.1% SDS and 0.05 % Tri- 
ton X-100 and transferred to a new tube. After centrifugation, supernatants 
were discarded and the pellets were eluted by boiling for 3 min in SDS- 
PAGE  sample  buffer  containing  2%  SDS  and  2%  2-mereaptoethanol. 
]mmuno-Precipitin was removed by centrifugation and the supernatant sam- 
ples were analyzed by SDS-PAGE. Immunoprecipitations with mAb 61 and 
mAb 19F4a were conducted identically except that Immuno-Precipitin was 
preabsorbed with either rabbit anti-rat IgG for mAb 61 or rabbit anti-mouse 
IgG for mAb FI0. 
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Immunoprecipitated or total protein samples were analyzed on SDS-poly- 
acrylamide gels (29) as modified by Cart et al. (16) to resolve the 43K pro- 
tein from nAchR ¢t subunit, creatine kinase, and actin. Resolving and stack- 
ing gels contained 8 % acrylamide/0.32 % N,N-methylene bis acryamide and 
4%  acrylamide/0.16%  N,N-methylene his acrylamide,  respectively, and 
electrode buffer consisted of 0.05 M Tris base, 0.38 M glycine, and 0.15% 
SDS (16).  Gels were processed for fluorograpby (6) for optimal 3H detec- 
tion and were exposed to Kodak XAR-5 film (Eastman Kodak Co., Roches- 
ter, NY). 
HPLC Analysis of ~H-Lipids Covalently Associated 
with the 431( Protein 
Three 60-ram cultures of BC3Ht cells were labeled for 4 h with [3H]my- 
ristate and 43K protein was immunoprecipitated from the cell lysate with 
anti-43K serum. Immunoprecipitated proteins were resolved by SDS-PAGE 
and the region of the unfixed, undried gel containing 43K protein excised 
using prestained molecular mass standards (Bethesda Research Laborato- 
ries) run in adjacent lanes as a guide. Excised gel slices were rinsed once 
rapidly with 10% methanol, followed by homogenization in 400 p.l of diges- 
tion buffer (20 mM glycine, 0.1% Triton X-100, pH 11.0, with one drop of 
toluene added to retard bacterial growth), and incubated at 37°C in the pres- 
ence of 400 lag of alkaline protease (type XXI; Sigma Chemical Co., St. 
Louis, MO) with end-over-end  mixing. After 4 h, another 400 lag of alkaline 
protease was added and the incubation was continued for an additional 10 h. 
Gel fragments were removed by centrifugation for 15 min in a microfuge 
and the supernatant, containing digested 43K protein, was supplemented 
with 20 I.tl of a 20 mg/ml stock of methyl myristate (Sigma Chemical Co.) 
in methanol. Samples were then lyophilized, redissolved in  1 ml of 83% 
methanol, 2 N HCI, and heated in a sealed Reactivial (Pierce Chemical Co., 
Rockford, IL) for 20 h at 95°C under nitrogen. The resulting hydrolysates 
were extracted four times with 1 ml of analytical grade petroleum ether and 
radioactivity in the aqueous and organic phases was determined by liquid 
scintillation counting. Lipids contained in the combined petroleum ether ex- 
tracts were separated and identified by reverse phase HPLC as described 
by Olson et al. (40). Briefly,  samples were evaporated to dryness under a 
steam of  nitrogen and resuspended in 250 lal HPLC grade methanol contain- 
ing 400 gg of methyl palmitate (Sigma Chemical Co.). This was loaded onto 
a 4.6-ram x  15-cm column (Ultrasphere-ODS Cm; Beckman Instruments, 
Inc., Palo Alto, CA) equilibrated in 80% acetonitrile (American Burdick 
and Jackson, Muskegon, MI) and eluted isocraticaUy at a  flow rate of 1 
ml/min. Fractions were collected at |-rain intervals and counted in 6 mt of 
3aTOB scintillation mixture (Research Products International Corp.,  Mt. 
Prospect, IL). The elution positions of the unlabeled methyl myristate and 
methyl palmitate internal standards were determined by UV absorption at 
214 nm. 
Hydroxylamine Treatment of  Fatty Acylated Proteins 
To examine the ability of hydroxylamine to release myristate from the 43K 
protein, [3H]myristate-labeled 43K protein was immunoprecipitated from 
metabolically labeled BC3H1 cells, eluted by boiling in SDS-PAGE sample 
buffer, and incubated with 7 vol of either 1.1 M hydroxylamine, pH 7.0, or 
1.1 M "Iris, pH 7.0, for 4 h at room temperature. Protein was then precipi- 
tated with 20% TCA, washed 4 times with ice-cold acetone, and redissolved 
in  SDS-PAGE sample buffer before analysis by  SDS-PAGE.  Total  fatty 
acylated proteins in BC3H1  cells were tested for hydroxylamine sensitivity 
in the same manner, substituting samples of BC3H1 cell lysates labeled with 
either [3H]myristate  or [3H]palmitate  for immunoprecipitated 43K. Alter- 
natively,  immunoprecipitated [3H]myristate-43K protein or labeled BC3H1 
lysates were treated with hydroxylamine after SDS-PAGE by soaking gels 
for 16 h in 1.0 M hydroxylamine or, as a control, 1.0 M Tris, pH 7.0 or pH 
10.0, as described by Olson et al.  (40). 
Preparation of  43K Protein-enriched Alkaline Extract 
from Torpedo Postsynaptic Membranes (pHll Extract) 
nAchR-rich membranes were isolated from the electric organ of Torpedo 
californica  using a modification (43) of the procedure of Sobel et al. (57). 
The 43K protein and other peripheral membrane proteins were extracted 
from these membranes by incubation at pH 11 (38). Briefly, membrane sus- 
pensions in 38%  sucrose were sedimented by centrifugation at  100,000 g 
for 20 min and resuspended in water to a concentration of 3 mg protein/ml. 
The pH was adjusted to 11.0 with NaOH and the preparation incubated at 
4°C for 1 h. Membranes were then pelleted as before, after which the super- 
natant extract was neutralized with 1 M HCI. Any insoluble material was 
removed from the extract by centrifugation at 100,000 g for 20 min and the 
supernatant was stored at  -70°C in single use aliquots.  As analyzed by 
SDS-PAGE and Coomassie Blue staining, •80%  of the protein in the pH 
11 extract consisted of the 43K protein with little or no detectable contami- 
nation with nAchR subunits. For competition experiments, the equivalent 
of 90 lal ofpH 11 extract (estimated by protein assay and SDS-PAGE to con- 
rain ,'~150 Isg of 43K protein) was used per 60-ram dish of cell lysate or 
30 I~1 in vitro translation reaction. No attempt was made to determine the 
minimum amount of pH 11 extract required for each competition reaction. 
In Vitro Transcription, Translation, and 
Immunoprecipitation of Torpedo 43K Protein 
The Eco RI fragment of the cDNA clone 43.1, comprising the coding region 
of Torpedo 43K protein (20), was subeloned into the Eco RI site of pGEM-l 
(Promega Biotec, Madison, WI). Plasmid was purified, linearized by diges- 
tion with Barn HI, and transcribed with T7 RNA polymerase in the presence 
of 1.0 mM m7G(5')ppp(5')G and nucleoside triphosphates (Pharmacia Fine 
Chemicals, Piscataway, NJ) using the Promega Biotec protocol. The mRNA 
was purified and translated in a  nuclease-treated, methionine-free rabbit 
reticulocyte lysate system (Bethesda Research Laboratories, Gaithersburg, 
MD) using 86 mM added potassium acetate and 50 laCi of [35S]methionine 
according to the suppliers protocol. Translation reactions were diluted 10- 
fold into  PBS  containing 0.5%  Triton  X-100,  l0 mM  EDTA,  200  taM 
leupeptin, 0.2 mg/ml a2-macroglobulin, 50 lag/ml aprotinin, and 500 gM 
benzamidine and immunoprecipitated with anti-43K serum after a preclear- 
ing step as described for BC3H1  cell lysates. 
Results 
Characterization of  Anti-43K Serum 
The polyclonal anti-43K serum used throughout this study 
was raised in a single rabbit that had been immunized with 
43K protein isolated from Torpedo electrocyte membranes. 
Reactivity of this antiserum with Torpedo electric organ pro- 
teins was assessed using procedures established for the char- 
acterization  of monoclonal  anti-Torpedo  43K  antibodies 
(7).  When Torpedo electric organ nAchR-rich membrane 
proteins were separated by SDS-PAGE,  transferred to nitro- 
cellulose, and immunoblotted with the anti-43K serum, a 
43,000-Mr single band was detected (data not shown). Two- 
dimensional electrophoresis of a sample containing a mix- 
ture of nAchR-rich membranes and Torpedo cytosol resolved 
the proteins migrating in the 43,000-Mr  region of the gel 
into several  species (Fig.  1 A). Among these, only a series 
of three isoelectric variants of pI 7-8 that are characteristic 
of Torpedo 43K protein (23, 44, 45) were recognized (Fig. 
1 B). There was no reactivity with creatine kinase or actin, 
both of which migrate in one-dimensional gels at a position 
similar to the 43K protein and are potential contaminants of 
43K protein preparations. 
Reactivity of the antiserum with 43K protein was further 
confirmed by its ability to recognize 43K protein synthesized 
in a cell-free system (Fig. 2).  A eDNA encoding Torpedo 
43K was transcribed in vitro and translated in a reticulocyte 
lysate devoid of endogenous translatable mRNA. Under these 
conditions 43K protein is the only labeled species synthe- 
sized.  The anti-43K serum immunoprecipitated a  labeled 
protein of "~43,000 Mr from these lysates (Fig.  2,  lane 1) 
whereas normal rabbit serum (lane 3) or preimmune serum 
did not.  Immunoprecipitation by the anti--43K  serum was 
blocked by an alkaline extract of Torpedo postsynaptic mem- 
branes (pH 11 extract) consisting of 80% pure 43K (lane 2), 
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sayed by  two-dimensional  immunoblot.  A 
sample containing Torpedo electric organ cy- 
tosol combined with nAchR-rich membranes 
was  resolved by two-dimensional gel  elec- 
trophoresis, and an immunoblot was prepared 
after electrophoretic transfer of the proteins 
to nitrocellulose. (A) Coomassie Blue stain of 
the portion of the gel containing immunore- 
activity. Solid triangles, 43K protein; open 
triangles, creatine kinase; and asterisk, actin. 
(B) Blot with antiserum at  1:1,000 dilution. 
indicating that the antiserum recognizes authentic 43K pro- 
tein in a  specific manner. 
Imraunoprecipitation of 43K Protein from 
Metabolically Radiolabeled BC3H1 Cells 
To determine whether 43K protein contains covalently bound 
lipid, differentiated BCH1 cells were metabolically labeled 
with  [35S]cysteine, [3H]myristate, or [3H]palmitate and de- 
tergent lysates of these cells were immunoprecipitated with 
the polyclonal anti-43K serum (Fig. 3). When such immuno- 
precipitates were prepared from [3sS]cysteine-labeled BC3H1 
cells and analyzed by SDS-PAGE and fluorography, a single 
band  that  comigrates  with  43K  protein  extracted  from 
Torpedo electric organ nAchR-rich membranes was obtained 
(Fig. 3, lane 1 ). That this 43,000-M, species is specifically 
immunoprecipitated authentic 43K protein is supported by 
the following: (a) it is not immunoprecipitated when normal 
rabbit  serum  (Fig.  3,  lane  2)  or  preimmune  serum  (not 
shown) is substituted for the anti-43K serum; (b it is present 
in other muscle-derived cell lines and primary cultures of 
embryonic rat myotubes but not rat H-4-II-E hepatoma cells 
(data not shown); (c) its electrophoretic mobility is distinct 
from that of the major actin band that is prominent in total 
BC3H1 lysates (lane 5); and (d) its immunoprecipitation is 
competitively inhibited by 43K protein-rich Torpedo pH 11 
extract whereas the immunoprecipitation of the a  subunit of 
the nAchR by an a-specific monoclonal antibody (mAb 61) 
is not (Fig. 4). LaRochelle and Froehner have determined a 
comparable molecular mass for the 43K protein in BC3H1 
cells  using  immunoaffinity chromatography and  immuno- 
blotting with anti-Torpedo 43K protein monoclonal antibod- 
ies (31). 
Identical immunoprecipitations were performed on lysates 
of BC3H1 cells that were metabolically labeled with [3H]- 
myristate  under  conditions  reported to  result  in  minimal 
("~30%)  conversion  of exogenously  added  fatty  acids  to 
amino acids in these cells (40). A single species that comi- 
grates with [35S]cysteine-labeled  43K protein was obtained 
(Fig.  3,  lane  3).  Immunoprecipitation  of this  3H-labeled 
band was specific in that it could be competed by pH 11 ex- 
tracted of Torpedo postsynaptic membranes (Fig. 4, lanes 3 
and 4) and required anti-43K serum (Fig. 3, lane 4). More- 
over, none of the major tritiated proteins of [3H]myristate- 
Figure  2.  Immunoprecipita- 
tion of in vitro-translated Tor- 
pedo 43K  protein with  anti- 
43K serum, mRNA encoding 
Torpedo 43K protein was syn- 
thesized in vitro from a eDNA 
template  and  translated  in  a 
nuclease-treated rabbit reticu- 
locyte  lysate system supple- 
mented with [35S]methionine, 
The translation  reaction was 
immunoprecipitated  with  ei- 
ther anti-43K  serum (lanes 1 
and 2) or normal rabbit serum 
(lane 3) and analyzed by SDS- 
PAGE. Anti-43K  serum  im- 
munoprecipitations were per- 
formed in the absence (lane 1 ) 
or presence (lane 2) of 43K protein partially purified from nAchR- 
rich Torpedo postsynaptic membranes by pH  11.0 extraction. 
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[3Hlmyristate-labeled 43K  protein.  BC3HI  cells  were  metaboli- 
cally  labeled  with  either  [3SS]cysteine (lanes  1,  2,  5,  and  6)  or 
pH]myristate (lanes 3  and 4),  lysed,  and aliquots of cell lysates 
immunoprecipitated with either anti-43K serum (lanes 1-4) or a 
monoclonal antibody specific for the ct subunit of the nAchR (mAb 
61; lanes 5 and 6). Immunoprecipitations were performed in the ab- 
sence (lanes 1, 3, and 5) or presence (lanes 2,  4,  and 6) of 43K 
protein partially purified  from nAchR-rich Torpedo postsynaptic 
membranes by pH  11.0 extraction. 
Figure 3.  Immunoprecipitation of 43K protein from metabolically 
labeled BC3H1 cells with anti--43K polyclonal and monoclonal an- 
tibodies.  BC3H1  cells  were  labeled  for 4  h  with  either  pS]cys- 
teine  or  [3H]myristate and  lysed  as  described  in  Materials  and 
Methods before immunoprecipitation or total protein analysis. Four 
times as much cell lysate was used per immunoprecipitation from 
[3H]myristate-labeled cells as from [35S]cysteine-labeled  cultures 
to compensate for the difference in labeling intensity with the two 
isotopes. (A) Immunoprecipitation of [35S]cysteine-labeled  (lanes 1 
and 2) or [~H]myristate-labeled (lanes 3 and 4) BC3HI cell lysates 
with either polyclonal anti-43K serum (lanes 1 and 3) or normal 
rabbit serum (lanes 2 and 4); total cellular proteins labeled with ei- 
ther [-~-SS]cysteine  (lane 5) or [3H]myristate  (lane 6). The asterisk 
marks the position of the major actin band in lane 5. (B) Immuno- 
precipitation of [35Slcysteine-labeled  (lanes  1 and  2)  or  [3Hlmy- 
ristate-labeled (lanes 3 and 4) BC3HI lysates with either anti-43K 
mAb 19F4a (lanes I and 3) or an irrelevant (anti-mouse leutinizing 
hormone) monoclonal antibody prepared similarly (lanes 2 and 4). 
labeled BC3HI total cell lysates (Fig.  3, lane 6) comigrated 
with  immunoprecipitated  43K  protein,  making  fortuitous 
nonspecific  precipitation  of the  43,000-Mr  band  extremely 
unlikely. A  monoclonal antibody raised versus purified Tor- 
pedo 43K protein,  19F4a  (Carr,  C.,  G.  D.  Fischback,  and 
J.  B.  Cohen,  manuscript  submitted  for  publication),  also 
specifically  recognized  both  [35S]cysteine-  and  [3H]myris- 
tate-labeled 43K protein from BC3H1 cell lysates (Fig. 3 B). 
Myristate  appears  to be incorporated  into the 43K  protein 
covalently  in  as  much  as the  [3H]myristate  label  remained 
associated with immunoprecipitated 43K protein after boil- 
ing  in SDS/2-mercaptoethanol  and  electrophoresis. 
In  contrast  to  the  results  obtained  with  [3H]myristate, 
very little radioactivity became associated with the 43K pro- 
tein  when  BC3HI  cells  were  incubated  with  [3H]palmitate 
under conditions  that resulted  in intense  labeling of several 
other proteins (see Fig. 6 B, lane 3  for example). As quanti- 
tated  by  densitometry,  the  43K  protein  was  labeled  '~25 
times  less  efficiently  with  [3H]paimitate  than  with  [3H]my- 
ristate (data not shown).  L0w-level labeling with [3H]palmi- 
late has been reported for several myristoylated proteins (11, 
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Figure 5. HPLC of fatty acids released from [3H]myristate-labeled 
43K protein. 43K protein was immunoprecipitated from three 60- 
mm dishes of BC3H1 cells that had been metabolically labeled with 
[3H]myristate  for 4  h.  The immunoprecipitated 43K protein was 
isolated by SDS-PAGE, digested  exhaustively with  alkaline pro- 
tease, and subjected to acid methanolysis as described in the text. 
The resulting hydrolysate was extracted with petroleum ether and 
fatty acid methyl esters contained in the organic phase analyzed by 
reverse phase HPLC on a Ct8 column. The distribution of radioac- 
tivity is compared to the elution position of fatty acid methyl ester 
internal standards (arrows) as determined by UV absorption. Back- 
ground radioactivity (20 dpm) was subtracted from each fraction. 
14,  18,  51) and has been demonstrated  in at least two cases 
to  arise  from  cellular  metabolism  of a  small  fraction  of 
[3H]palmitate  to  [3H]myristate  during  the  labeling  period 
(11,  18).  It is therefore likely that [3H]palmitate is incorpo- 
rated into the 43K protein only after conversion to [3H]my- 
ristate or amino acids. 
Chemical Identification of the Fatty Acid Covalently 
Bound to the 43K Protein as Myristate 
Although some similarities are apparent,  SDS-PAGE analy- 
sis  of proteins  labeled  during  a  4-h  incubation  of BC3H1 
cells with either [35S]cysteine or [3H]myristate demonstrates 
that each precursor labels a  distinct  set of proteins  (Fig.  3, 
lanes  5  and  6).  The  difference  in  these  labeling  patterns 
suggests  that  there  is  little  conversion  of  [3H]myristate  to 
amino acid metabolites,  making it likely that  [3H]myristate 
is incorporated into 43K protein without modification.  This 
was  confirmed  by  chemical  analysis  of  [3H]myristate-la- 
beled 43K protein. Briefly, BC3HI cells were incubated with 
[3H]myristate for 4  h  and  labeled 43K protein was isolated 
by immunoprecipitation and SDS-PAGE. Gel slices contain- 
ing  [3H]-43K protein were exhaustively digested with alka- 
line protease, after which the eluted peptides were subjected 
to acid methanolysis at 95°C for 20 h. The resulting hydroly- 
sate (containing  free amino acids and  fatty acid methyl es- 
ters)  was  extracted  with  petroleum  ether  and  the  organic 
phase  analyzed  by  reverse-phase  HPLC.  All  of the  3H  ra- 
dioactivity recovered from the HPLC column (yield  =  70- 
80 % of injected radioactivity) migrated at the position of the 
methyl  myristate  internal  standard  and  was  well-resolved 
from methyl palmitate (Fig.  5).  Moreover, only '~5% of the 
43K  protein-associated  radioactivity  partitioned  into  the 
aqueous phase after acid methanolysis, indicating negligible 
conversion  of label  to  amino  acids  or  other  water-soluble 
species before incorporation  into 43K protein.  Thus,  virtu- 
ally all of the radioactivity recovered from the 43K protein 
in  [3H]myristate-labeled  cells  is  in  the  form  of  authentic 
myristate. 
Figure 6.  Hydroxylamine stability of the  linkage of myristate to 
43K protein. BC3H1  cells were metabolically labeled with either 
[3H]myristate,  [3H]palmitate,  or  [35]cysteine for 4  h  and  lysed. 
Equal aliquots of 43K protein immunoprecipitated from these ly- 
sates or of total cell lysate were then treated for 4 h at room tempera- 
ture with either 1 M Tris, pH 7.0, (lanes 1, 3, and 5) or 1 M hydrox- 
ylamine pH 7.0 (lanes 2, 4, and 6) before analysis by SDS-PAGE. 
(A)  43K protein  immunoprecipitated  from  [3H]myristate-labeled 
cells with anti-43K serum. (B) Total cellular protein from cells la- 
beled  with  either  [3H]myristate  (lanes  1  and  2),  [3H]palmitate 
(lanes 3 and 4),  or [35S]cysteine (lanes 5  and 6). 
Mode of  Attachment of  Myristate to the 43K Protein 
A  fatty acid molecule can be linked to protein via an ester, 
thioester, or amide bond (41).  Palmitate is incorporated into 
proteins posttranslationally,  usually via an ester or thioester 
linkage  (41,  65).  In contrast,  myristoylation is a  cotransla- 
tional  event  (68)  in  which  myristate  is  typically  added  to 
amino terminal glycine residues by means of an amide bond. 
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was incubated with hydroxylamine before (in solution; Fig. 
6 A, lanes I  and 2) or after (in a fixed slab gel) SDS-PAGE; 
similar results  were  obtained  when  gel  slices  containing 
[3H]myristate-43K protein were soaked for up to 16 h in pH 
10 hydroxylamine (1.0 M) or 0.1  M  KOH, 40%  methanol 
(data not shown).  As expected, the major proteins labeled 
with [3H]myristate in BC3H1 cells were also resistant to hy- 
droxylamine (Fig. 6 B, lanes I and 2) whereas identical treat- 
ment of lysates of [3H]palmitate labeled cells removed large 
amounts of radioactivity from most of the prominent 3H- 
containing proteins (Fig. 6 B, lanes 3 and 4). Based on the 
criteria of hydroxylamine stability, we conclude that myris- 
tate is most likely bound to the 43K protein by an amide-type 
linkage. 
To help distinguish between co- and posttranslational addi- 
tion of myristate, we examined the effect of inhibition of pro- 
tein synthesis on the incorporation of [3H]myristate into the 
43K protein  (Fig.  7).  Treatment of BC3H1  cells with 50 
~tg/ml cycloheximide has previously been shown to reduce 
protein synthesis in these cells to <5 % of control within 2 
min (42). This concentration of cycloheximide abolished all 
detectable incorporation of [3H]myristate into BC3H1  cel- 
lular proteins (lane 4),  including immunoprecipitated 43K 
protein (lane 2), during a 4-h labeling period. In contrast, 
considerable  labeling  of proteins  with  [3H]palmitate con- 
tinued in the presence of cycloheximide (compare lane 5 with 
6), indicating addition of [3H]palmitate to preexisting pro- 
teins. These results are consistent with cotranslational addi- 
tion of myristate to 43K protein and suggest that myristate 
does not turn over during the lifetime of the protein. Similar 
findings have been reported for several other myristoylated 
proteins (13, 32, 42). 
Figure 7. Effect of cycloheximide on the incorporation of [3H]my- 
ristate into 43K protein.  BC3H1 ceils were labeled for 4 h with 
[3Hlmyristate (lanes 1-4) or [3H]palmitate (lanes 5 and 6) in ei- 
ther the absence or presence of 50 gg/ml cycloheximide. At the end 
of  the labeling period the cells were lysed and either immunoprecip- 
itated with anti-43K serum (lanes I and 2) or analyzed for total la- 
beled protein content (lanes 3-6). Lanes 1, 3, and 5, control cul- 
tures labeled in the absence of cycloheximide. Lanes 2, 4, and 6, 
cycloheximide added  to  cultures  10  min  before addition  of 3H 
label. 
The nature of the linkage of myristate to 43K protein was in- 
vestigated by examining the stability of this bond to hydroxyl- 
amine. Hydroxylamine is a nucleophile that hydrolyzes thio- 
ester and  (less  easily) ester bonds  but has  little effect on 
amide linkages (32, 33). A 4-h treatment with 1 M hydroxyl- 
amine at pH 7.4 resulted in minimal release of radioactivity 
from 43K protein immunoprecipitated from [3H]myristate- 
Discussion 
The  results  of the  HPLC  analysis  presented here clearly 
demonstrate that the 43K protein is myristoylated in BC3H1 
mouse muscle cells. Fatty acid acylation of 43K protein is 
very specific for myristate, with little or no incorporation of 
palmitate, and appears to be cotranslational in as much as it 
is completely inhibited by cycloheximide. In these respects 
myristoylation of the 43K protein resembles that of several 
other proteins (11, 13, 32, 35, 42). In virtually all cases exam- 
ined, protein myristoylation takes place on amino terminal 
glycine residues via an amide bond (55, 62, 65). Myristate 
being linked to 43K protein in a similar manner is supported 
by the following: the presence of a good consensus sequence 
for myristoylation at  the amino terminus of both Torpedo 
(20) and mouse (19a) 43K protein; the finding that Torpedo 
43K protein is blocked to NH2-terminal Edman degradation 
(16);  and the stability of the association of myristate with 
43K protein to hydroxylamine that is indicative of an amide 
bond. Further experiments will be required, however, before 
this can be definitively established. 
The functional role of myristate is unknown for most pro- 
teins. However, point mutations that prevent myristoylation 
by  changing  amino  terminal  glycine  residues  to  alanine, 
valine,  or glutamic  acid  have important biological conse- 
quences in the few cases examined.  For example, abolish- 
ment of myristoylation of the virally encoded tyrosine pro- 
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associating with membranes and renders it nontransforming, 
presumably by preventing its association with putative mem- 
brane-bound substrates whose phosphorylation is necessary 
for transformation  (12,  26,  27).  Similarly,  mutation of the 
NH2-terminal  glycine  of the  gag  polyprotein  precursor of 
Mason-Pfizer monkey virus (48) or of Moloney murine leu- 
kemia virus (47) appears to completely inhibit virus assem- 
bly (47) and/or budding (48) by preventing the association 
of the gag-encoded structural proteins with the inner plasma 
membrane.  These  examples  point to a  functional  role  for 
myristoylation in the anchoring of cytoplasmically  synthe- 
sized proteins to cellular membranes, presumably via inter- 
action of the myristate  moiety  with  the lipid  bilayer.  The 
finding that some myristoylated proteins are soluble rather 
than membrane bound (15, 42) suggests, however, that acyla- 
tion with myristate may also serve other purposes such as 
facilitating specific protein-protein interactions, influencing 
protein folding,  or permitting transient,  reversible associa- 
tion of proteins with cellular membranes. 
Defining the role of 43K protein myristoylation is compli- 
cated by the fact that the function of the protein itself is un- 
known.  The colocalization of the 43K protein with nAchR 
clusters and the effect of removal of 43K protein on their sta- 
bility have been interpreted as suggesting that 43K protein 
is involved in anchoring nAchRs at the postsynaptic mem- 
brane, perhaps by acting as a mediator between the receptor 
and the underlying cytoskeletal network (44, 67). Myristoy- 
lation of the 43K protein could aid in this proposed function 
by allowing direct association of 43K protein with the plasma 
membrane  via  lipid-lipid  interactions.  This  possibility  is 
supported  by  the  finding  that  43K  protein  isolated  from 
Torpedo postsynaptic membranes binds tightly and rapidly 
to pure liposomes (46), even though 43K protein would not 
be predicted to be particularly hydrophobic on the basis of 
its amino acid  sequence.  The apparent lipophilicity  of the 
43K protein cannot, however, account for why it is detected 
in situ only at those areas of the plasma membrane that are 
rich in nAchRs (53). If myristoylation of 43K protein is in- 
volved in this preferential subcellular localization, it may be 
to promote specific interactions between the 43K protein and 
other  proteins  such as the  nAchR or cytoskeletal  compo- 
nents. In this respect it is interesting to note that vinculin (10, 
28) and ankyrin (58), both of which have been implicated in 
plasma membrane-cytoskeleton  interactions,  contain cova- 
lenfly  bound  myristate  and/or  palmitate.  The  coextensive 
distribution of the 43K protein with nAchRs observed in vivo 
most likely results, at least in part, from affinity of the 43K 
protein for specific proteins as well as for lipids in general; 
either  or both types  of interactions  might conceivably  be 
mediated by myristate.  Dissecting the function of myristate 
in the 43K protein will be best accomplished by specifically 
abolishing its myristoylation using site-directed mutagenesis 
and examining the subcellular distribution of the altered pro- 
tein.  Experiments  directed  towards this  goal  (currently  in 
progress)  should confirm the molecular site of myristoyla- 
tion and may also shed light on the role of the 43K protein 
at the postsynaptic membrane. 
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